SLNO Soleno Therapeutics Inc.

2.31
-0.1  -4%
Previous Close 2.4
Open 2.42
Price To Book 2.4
Market Cap 73236946
Shares 31,755,169
Volume 294,320
Short Ratio
Av. Daily Volume 1,867,513

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data due late-2019.
Diazoxide Choline Controlled-Release (DCCR) - DESTINY PWS
Prader-Willi syndrome (PWS)